|
1
|
Zhang CL, Wu LL and Li L: Research
progress of complement-C1q/tumor necrosis factor-related protein 3.
Sheng Li Xue Bao. 69:666–676. 2017.PubMed/NCBI
|
|
2
|
Schäffler A and Buechler C: CTRP family:
Linking immunity to metabolism. Trends Endocrinol Metab.
23:194–204. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Han M, Wang B, Zhu M and Zhang Y: C1QTNF6
as a novel biomarker regulates cellular behaviors in A549 cells and
exacerbates the outcome of lung adenocarcinoma patients. In Vitro
Cell Dev Biol Anim. 55:614–621. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lin W, Chen X, Chen T, Liu J, Ye Y, Chen
L, Qiu X, Chia-Hsien Cheng J, Zhang L, Wu J and Qiu S: C1QTNF6 as a
novel diagnostic and prognostic biomarker for clear cell renal cell
carcinoma. DNA Cell Biol. 39:1000–1011. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang L, Liu Z, Duan L, Ma B and Sun Z: C1q
tumor necrosis factor-related protein 6 (CTRP6) inhibits the
proliferation and migration of ovarian cancer cells. Xi Bao Yu Fen
Zi Mian Yi Xue Za Zhi. 31:1664–1668. 2015.(In Chinese). PubMed/NCBI
|
|
6
|
Wan X, Zheng C and Dong L: Inhibition of
CTRP6 prevented survival and migration in hepatocellular carcinoma
through inactivating the AKT signaling pathway. J Cell Biochem.
120:17059–17066. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qu HX, Cui L, Meng XY, Wang ZJ, Cui YX, Yu
YP, Wang D and Jiang XJ: C1QTNF6 is overexpressed in gastric
carcinoma and contributes to the proliferation and migration of
gastric carcinoma cells. Int J Mol Med. 43:621–629. 2019.PubMed/NCBI
|
|
8
|
Takeuchi T, Adachi Y and Nagayama T:
Expression of a secretory protein C1qTNF6, a C1qTNF family member,
in hepatocellular carcinoma. Anal Cell Pathol (Amst). 34:113–121.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kishore U, Gaboriaud C, Waters P, Shrive
AK, Greenhough TJ, Reid KB, Sim RB and Arlaud GJ: C1q and tumor
necrosis factor superfamily: Modularity and versatility. Trends
Immunol. 25:551–561. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wong GW, Krawczyk SA, Kitidis-Mitrokostas
C, Revett T, Gimeno R and Lodish HF: Molecular, biochemical and
functional characterizations of C1q/TNF family members:
Adipose-tissue-selective expression patterns, regulation by
PPAR-gamma agonist, cysteine-mediated oligomerizations,
combinatorial associations and metabolic functions. Biochem J.
416:161–177. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim MJ, Lee W, Park EJ and Park SY:
C1qTNF-related protein-6 increases the expression of interleukin-10
in macrophages. Mol Cells. 30:59–64. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wong GW, Wang J, Hug C, Tsao TS and Lodish
HF: A family of Acrp30/adiponectin structural and functional
paralogs. Proc Natl Acad Sci USA. 101:10302–10307. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kong M, Gao Y, Guo X, Xie Y and Yu Y: Role
of the CTRP family in tumor development and progression. Oncol
Lett. 22:7232021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen L and Su G: Identification of CTRP1
as a prognostic biomarker and oncogene in human glioblastoma.
Biomed Res Int. 2019:25824162019.PubMed/NCBI
|
|
15
|
Maeda T, Jikko A, Abe M, Yokohama-Tamaki
T, Akiyama H, Furukawa S, Takigawa M and Wakisaka S: Cartducin, a
paralog of Acrp30/adiponectin, is induced during chondrogenic
differentiation and promotes proliferation of chondrogenic
precursors and chondrocytes. J Cell Physiol. 206:537–544. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Akiyama H, Furukawa S, Wakisaka S and
Maeda T: CTRP3/cartducin promotes proliferation and migration of
endothelial cells. Mol Cell Biochem. 304:243–248. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao J, Gu G, Lu L and Wang X: Research
progress of C1q tumor necrosis factor-related protein 4.
International Journal of Cardiovascular Diseases 99–101; 2016
|
|
18
|
Thanasupawat T, Glogowska A, Burg M, Wong
GW, Hoang-Vu C, Hombach-Klonisch S and Klonisch T: RXFP1 is
targeted by complement C1q tumor necrosis factor-related factor 8
in brain cancer. Front Endocrinol (Lausanne). 6:1272015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hano K, Hatano K, Saigo C, Kito Y, Shibata
T and Takeuchi T: An adiponectin paralog protein, CTRP6 decreased
the proliferation and invasion activity of oral squamous cell
carcinoma cells: Possible interaction with laminin receptor
pathway. Mol Biol Rep. 46:4967–4973. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gou J, Kang S, Qu H and Cui Y: Expression
of complement C1q/tumor necrosis factor-related protein 6 in colon
cancer. Journal of Gastroenterology and Hepatology. 28:313–316.
2019.
|
|
21
|
Kirketerp-Møller N, Bayarri-Olmos R,
Krogfelt KA and Garred P: C1q/TNF-Related protein 6 is a pattern
recognition molecule that recruits collectin-11 from the complement
system to ligands. J Immunol. 204:1598–1606. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lei X, Seldin MM, Little HC, Choy N,
Klonisch T and Wong GW: C1q/TNF-related protein 6 (CTRP6) links
obesity to adipose tissue inflammation and insulin resistance. J
Biol Chem. 292:14836–14850. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu E, Yin C, Yi X and Liu Y: Knockdown of
CTRP6 inhibits high glucose-induced oxidative stress, inflammation
and extracellular matrix accumulation in mesangial cells through
regulating the Akt/NF-kB pathway. Clin Exp Pharmacol Physiol.
47:1203–1211. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Y, Sun J, Gu L and Gao X: Protective
effect of CTRP6 on cerebral ischemia/reperfusion injury by
attenuating inflammation, oxidative stress and apoptosis in PC12
cells. Mol Med Rep. 22:344–352. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Altomare DA and Testa JR: Perturbations of
the AKT signaling pathway in human cancer. Oncogene. 24:7455–7464.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pintha K, Chaiwangyen W, Yodkeeree S,
Suttajit M and Tantipaiboonwong P: Suppressive effects of
rosmarinic acid rich fraction from perilla on oxidative stress,
inflammation and metastasis ability in A549 cells exposed to PM via
C-Jun, P-65-Nf-kb and Akt signaling pathways. Biomolecules.
11:10902021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bou Malhab LJ and Abdel-Rahman WM: Obesity
and inflammation: Colorectal cancer engines. Curr Mol Pharmacol.
15:620–646. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu X, Yao L, Qu J, Liu L, Lu N, Wang J
and Zhang J: Cancer-associated fibroblast infiltration in gastric
cancer: The discrepancy in subtypes pathways and immunosuppression.
J Transl Med. 19:3252021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhai J, Shen J, Xie G, Wu J, He M, Gao L,
Zhang Y, Yao X and Shen L: Cancer-associated fibroblasts-derived
IL-8 mediates resistance to cisplatin in human gastric cancer.
Cancer Lett. 454:37–43. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chi X, Liu Z, Wei W, Hu X, Wang Y, Wang H
and Xu B: Selenium-rich royal jelly inhibits hepatocellular
carcinoma through PI3K/AKT and VEGF pathways in H22 tumor-bearing
mice. Food Funct. 12:9111–9127. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y
and Li Y: Inflammation and tumor progression: signaling pathways
and targeted intervention. Signal Transduct Target Ther. 6:2632021.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Z, Chi H, Zhu W, Yang G, Song J, Mo L,
Zhang Y, Deng Y, Xu F, Yang J, et al: Cadmium induces renal
inflammation by activating the NLRP3 inflammasome through
ROS/MAPK/NF-kB pathway in vitro and in vivo. Arch Toxicol.
95:3497–3513. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Eyre S, Hinks A, Bowes J, Flynn E, Martin
P, Wilson AG, Morgan AW, Emery P, Steer S, Hocking LJ, et al:
Overlapping genetic susceptibility variants between three
autoimmune disorders: Rheumatoid arthritis, type 1 diabetes and
coeliac disease. Arthritis Res Ther. 12:R1752010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ray AL, Berggren KL, Restrepo Cruz S, Gan
GN and Beswick EJ: Inhibition of MK2 suppresses IL-1β, IL-6, and
TNF-α-dependent colorectal cancer growth. Int J Cancer.
142:1702–1711. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang T, Zhang J, Zhou J, Zhu M, Wang L and
Yan L: Resveratrol inhibits Interleukin-6 induced invasion of human
gastric cancer cells. Biomed Pharmacother. 99:766–773. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xia Y, Khoi PN, Yoon HJ, Lian S, Joo YE,
Chay KO, Kim KK and Jung YD: Piperine inhibits IL-1β-induced IL-6
expression by suppressing p38 MAPK and STAT3 activation in gastric
cancer cells. Mol Cell Biochem. 398:147–156. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shokrzadeh M, Mohammadpour A, Hoseini V,
Abediankenari S, Ghassemi-Barghi N and Tabari YS: Serum cytokine OF
IL-2, IL-10 and IL-12 levels in patients with stomach
adenocarcinoma. Arq Gastroenterol. 55:385–389. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mohamed EA, Bassiouny K, Alshambky AA and
Khalil H: Anticancer properties of N,N-dibenzylasparagine as an
Asparagine (Asp) analog, using colon cancer caco-2 cell line. Asian
Pac J Cancer Prev. 23:2531–2540. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Neurath MF: IL-23 in inflammatory bowel
diseases and colon cancer. Cytokine Growth Factor Rev. 45:1–8.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kern L, Mittenbühler MJ, Vesting AJ,
Ostermann AL, Wunderlich CM and Wunderlich FT: Obesity-Induced TNFα
and IL-6 signaling: The missing link between obesity and
inflammation-driven liver and colorectal cancers. Cancers (Basel).
11:242018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pu X and Chen D: Targeting adipokines in
obesity-related tumors. Front Oncol. 11:6859232021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sadeghi A, Fadaei R, Moradi N, Fouani FZ,
Roozbehkia M, Zandieh Z, Ansaripour S, Vatannejad A and
Doustimotlagh AH: Circulating levels of C1q/TNF-α-related protein 6
(CTRP6) in polycystic ovary syndrome. IUBMB Life. 72:1449–1459.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wu W, Xu K, Li M, Zhang J and Wang Y:
MicroRNA-29b/29c targeting CTRP6 influences porcine adipogenesis
via the AKT/PKA/MAPK Signalling pathway. Adipocyte. 10:264–274.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wu W, Ji M, Xu K, Zhang D, Yin Y, Huang X,
Peng Y and Zhang J: Knockdown of CTRP6 reduces the deposition of
intramuscular and subcutaneous fat in pigs via different signaling
pathways. Biochim Biophys Acta Mol Cell Biol Lipids.
1865:1587292020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wu WJ, Mo DL, Zhao CZ, Zhao C, Chen YS,
Pang WJ and Yang GS: Knockdown of CTRP6 inhibits adipogenesis via
lipogenic marker genes and Erk1/2 signalling pathway. Cell Biol
Int. 39:554–562. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang M, Tang X, Li L, Liu D, Liu H, Zheng
H, Deng W, Zhao X and Yang G: C1q/TNF-related protein-6 is
associated with insulin resistance and the development of diabetes
in Chinese population. Acta Diabetol. 55:1221–1229. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen HY, Yang MD, Chou YC, Ma YS, Peng SF,
Liao CL, Chen PY, Hsia TC, Lien JC and Chen CH: Ouabain Suppresses
Cell Migration and Invasion in Human Gastric Cancer AGS Cells
Through the Inhibition of MMP Signaling Pathways. Anticancer Res.
41:4365–4375. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kasprzak A: Insulin-Like Growth Factor 1
(IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer. Int J
Mol Sci. 22:64342021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kruszyna Ł, Murawa D, Jagodziński PP,
Oszkinis G and Krasiński Z: The expression and prognostic
significance of VEGF and CXCR4 in gastric cancer: Correlation with
Angiogenesis, Lymphangiogenesis and Progression. Curr Issues Mol
Biol. 44:3075–3088. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Batzorig U, Wei PL, Wang W, Huang CY and
Chang YJ: Glucose-Regulated Protein 94 Mediates the Proliferation
and Metastasis through the Regulation of ETV1 and MAPK Pathway in
Colorectal Cancer. Int J Med Sci. 18:2251–2261. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wiśniewska W, Kopka M, Siemiątkowska K,
Fudalej MM, Sobiborowicz A and Badowska-Kozakiewicz AM: The
complexity of tumour angiogenesis based on recently described
molecules. Contemp Oncol (Pozn). 25:33–44. 2021.PubMed/NCBI
|
|
52
|
Phung TL, Ziv K, Dabydeen D, Eyiah-Mensah
G, Riveros M, Perruzzi C, Sun J, Monahan-Earley RA, Shiojima I,
Nagy JA, et al: Pathological angiogenesis is induced by sustained
Akt signaling and inhibited by rapamycin. Cancer Cell. 10:159–170.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Si Y, Fan W and Sun L: A review of the
relationship between CTRP family and coronary artery disease. Curr
Atheroscler Rep. 22:222020. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yamaguchi S, Shibata R, Ohashi K, Enomoto
T, Ogawa H, Otaka N, Hiramatsu-Ito M, Masutomi T, Kawanishi H,
Murohara T and Ouchi N: C1q/TNF-Related protein 9 promotes
revascularization in response to ischemia via an eNOS-Dependent
manner. Front Pharmacol. 11:13132020. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
He L, Wang W, Shi H, Jiang C, Yao H, Zhang
Y, Qian W and Lin R: THBS4/integrin α2 axis mediates BM-MSCs to
promote angiogenesis in gastric cancer associated with chronic
Helicobacter pylori infection. Aging (Albany NY). 13:19375–19396.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Auyeung KK and Ko JK: Angiogenesis and
oxidative stress in metastatic tumor progression: Pathogenesis and
novel therapeutic approach of colon cancer. Curr Pharm Des.
23:3952–3961. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhao Z, Gao J, Li C, Xu X, Hu Y and Huang
S: Reactive oxygen species induce endothelial differentiation of
liver cancer stem-like sphere cells through the activation of
Akt/IKK signaling pathway. Oxid Med Cell Longev. 2020:16216872020.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Lin JX, Weng XF, Xie XS, Lian NZ, Qiu SL,
Wang JB, Lu J, Chen QY, Cao LL, Lin M, et al: CDK5RAP3 inhibits
angiogenesis in gastric neuroendocrine carcinoma by modulating
AKT/HIF-1α/VEGFA signaling. Cancer Cell Int. 19:2822019. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Chung SY, Chao TC and Su Y: The
stemness-high human colorectal cancer cells promote angiogenesis by
producing higher amounts of angiogenic cytokines via activation of
the Egfr/Akt/Nf-kB pathway. Int J Mol Sci. 22:13552021. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Li HY, Li M, Luo CC, Wang JQ and Zheng N:
Lactoferrin exerts antitumor effects by inhibiting angiogenesis in
a HT29 human colon tumor model. J Agric Food Chem. 65:10464–10472.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wang L, Yi T, Kortylewski M, Pardoll DM,
Zeng D and Yu H: IL-17 can promote tumor growth through an
IL-6-Stat3 signaling pathway. J Exp Med. 206:1457–1464. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Carling D: AMPK. Curr Biol. 14:R2202004.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Huang H, Wang L, Qian F, Chen X, Zhu H,
Yang M, Zhang C, Chu M, Wang X and Huang X: Liraglutide via
activation of AMP-Activated protein kinase-hypoxia inducible
factor-1α-Heme Oxygenase-1 signaling promotes wound healing by
preventing endothelial dysfunction in diabetic mice. Front Physiol.
12:6602632021. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Zulato E, Bergamo F, De Paoli A, Griguolo
G, Esposito G, De Salvo GL, Mescoli C, Rugge M, Nardin M, Di Grazia
L, et al: Prognostic significance of AMPK activation in advanced
stage colorectal cancer treated with chemotherapy plus bevacizumab.
Br J Cancer. 111:25–32. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Dai W, Wang Y, Yang T, Wang J, Wu W and Gu
J: Downregulation of exosomal CLEC3B in hepatocellular carcinoma
promotes metastasis and angiogenesis via AMPK and VEGF signals.
Cell Commun Signal. 17:1132019. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Wang Y, Wang B, Guerram M, Sun L, Shi W,
Tian C, Zhu X, Jiang Z and Zhang L: Deoxypodophyllotoxin suppresses
tumor vasculature in HUVECs by promoting cytoskeleton remodeling
through LKB1-AMPK dependent Rho A activatio. Oncotarget.
6:29497–29512. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Sen K, Banerjee S and Mandal M: Dual drug
loaded liposome bearing apigenin and 5-Fluorouracil for synergistic
therapeutic efficacy in colorectal cancer. Colloids Surf B
Biointerfaces. 180:9–22. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Qu LH, Hong X, Zhang Y, Cong X, Xiang RL,
Mei M, Su JZ, Wu LL and Yu GY: C1q/tumor necrosis factor-related
protein-6 attenuates TNF-α-induced apoptosis in salivary acinar
cells via AMPK/SIRT1-modulated miR-34a-5p expression. J Cell
Physiol. 236:5785–5800. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Xie YH, Xiao Y, Huang Q, Hu XF, Gong ZC
and Du J: Role of the CTRP6/AMPK pathway in kidney fibrosis through
the promotion of fatty acid oxidation. Eur J Pharmacol.
892:1737552021. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Moon HS, Liu X, Nagel JM, Chamberland JP,
Diakopoulos KN, Brinkoetter MT, Hatziapostolou M, Wu Y, Robson SC,
Iliopoulos D and Mantzoros CS: Salutary effects of adiponectin on
colon cancer: In vivo and in vitro studies in mice. Gut.
62:561–570. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Iwata Y, Yasufuku I, Saigo C, Kito Y,
Takeuchi T and Yoshida K: Anti-fibrotic properties of an
adiponectin paralog protein, C1q/TNF-related protein 6 (CTRP6), in
diffuse gastric adenocarcinoma. J Cancer. 12:1161–1168. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Murayama MA, Kakuta S, Inoue A, Umeda N,
Yonezawa T, Maruhashi T, Tateishi K, Ishigame H, Yabe R, Ikeda S,
et al: CTRP6 is an endogenous complement regulator that can
effectively treat induced arthritis. Nat Commun. 6:84832015.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Lei H, Wu D, Wang JY, Li L, Zhang CL, Feng
H, Fu FY and Wu LL: C1q/tumor necrosis factor-related protein-6
attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A
pathway and inhibiting myofibroblast differentiation. Basic Res
Cardiol. 110:352015. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Dong X, Hu H, Fang Z, Cui J and Liu F:
CTRP6 inhibits PDGF-BB-induced vascular smooth muscle cell
proliferation and migration. Biomed Pharmacother. 103:844–850.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Li R, Du J, Yao Y, Yao G and Wang X:
Adiponectin inhibits high glucose-induced angiogenesis via
inhibiting autophagy in RF/6A cells. J Cell Physiol.
234:20566–20576. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Shah D, Sandhu K, Das P and Bhandari V:
Adiponectin ameliorates hyperoxia-induced lung endothelial
dysfunction and promotes angiogenesis in neonatal mice. Pediatr
Res. 91:545–555. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Zhang N, Zhou J, Zhou Y and Guan F:
MicroRNA-148a inhibits hepatocellular carcinoma cell growth via
epithelial-to-mesenchymal transition and PI3K/AKT signaling
pathways by targeting death receptor-5. Appl Biochem Biotechnol.
194:2731–2746. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Sp N, Kang DY, Jo ES, Lee JM and Jang KJ:
Iron metabolism as a potential mechanism for inducing
TRAIL-Mediated extrinsic apoptosis using methylsulfonylmethane in
embryonic cancer stem cells. Cells. 10:28472021. View Article : Google Scholar : PubMed/NCBI
|
